20161122_mc2-portrait-04

MC2 Therapeutics A/S appoints Anders D. Hove and Paul L. Berns to the Board of Directors

POSTED: August 1, 2017

Copenhagen, August, 2017 – MC2 Therapeutics A/S, a clinical-stage dermatology and eye care company, has appointed Dr. Anders D. Hove and Mr. Paul L. Berns to serve on the Board.

“On ...

READ FULL ARTICLE

MC2 Therapeutics to present data at the 2017 ARVO Annual Meeting highlighting the therapeutic potential of PAD® Techno.

POSTED: May 1, 2017

Copenhagen, February 24th, 2017 – MC2 Therapeutics today announced that two abstracts were accepted for poster presentation at the 2017 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting ...

READ FULL ARTICLE

© mc2 therapeautics 2016